Outcome of totally implantable venous-access port-related infections
Médecine et Maladies Infectieuses · 2016-02 · 46 (1) · 32-38
DOI: 10.1016/j.medmal.2015.12.006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Médecine et Maladies Infectieuses, 2016-02. Verfasst von M Vidal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Service des maladies infectieuses et tropicales, centre hospitalier et universitaire, 58, rue Montalembert, 63000 Clermont-Ferrand, France. Electroni…. Hauptthemen laut MEDLINE: Device Removal. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: We aimed to study factors associated with the outcome of totally implantable venous-access port (TIVAP)-related infections. PATIENTS AND METHODS: We conducted a prospective and observational cohort study of patients presenting with a solid tumor and TIVAP-related infection. RESULTS: We monitored 97 patients for 12weeks. The case fatality at 12weeks was high (54%). Factors associated with case fatality at week 12 included patients' underlying cancer (metastatic status, parenteral nutrition, home care). Infectious complications (local abscess, hematogenous metastases, infection recurrence, septic shock) were frequently observed (48%). The delay in TIVAP removal was the only variable significantly associated with complications (TIVAP removed more than a week after removal decision, P=0.001, or more than a week after onset of clinical symptoms, P=0.002). On the basis of IDSA guidelines, we also observed that 25% of patients whose TIVAP had been removed could have benefited from a conservative treatment. Infections occurring within a month of TIVAP implantation were significantly associated with a Staphylococcus aureus infection (P=0.008). CONCLUSION: Case fatality is high in this population of patients due to the poor status of patients. TIVAP should be promptly removed when appropriate but the patient's poor status might delay or even prevent its removal. Some patients could instead benefit from a conservative treatment. There is currently no recommendation for this therapeutic option and studies are needed to clarify its efficacy. Additionally, infection occurring within a month of TIVAP insertion could be a supplementary criterion for removal as S. aureus is associated with early infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service des maladies infectieuses et tropicales, centre hospitalier et universitaire, 58, rue Montalembert, 63000 Clermont-Ferrand, France. Electronic address: mvidal@chu-clermontferrand.fr.
- Service d'hygiène hospitalière, centre Jean-Perrin, 58, rue Montalembert, BP 392, 63011 Clermont-Ferrand cedex 1, France.
- Service des maladies infectieuses et tropicales, médecine interne, centre hospitalier, BP 1125, 73011 Chambéry, France.
- Service de médecine interne, centre hospitalier, 50, avenue de la République, BP 229, 15002 Aurillac cedex, France.
- Délégation recherche clinique & innovation, CHU de Clermont-Ferrand, villa annexe IFSI, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France.
- Service des maladies infectieuses et tropicales, centre hospitalier et universitaire, 58, rue Montalembert, 63000 Clermont-Ferrand, France.
Zitieren
APA
Vidal, M., Genillon, J. P., Forestier, E., Trouiller, S., Pereira, B., Mrozek, N., Aumeran, C., & Lesens, O. (2016). Outcome of totally implantable venous-access port-related infections. Médecine et Maladies Infectieuses, 46(1), 32-38. https://doi.org/10.1016/j.medmal.2015.12.006
Vancouver
Vidal M, Genillon JP, Forestier E, Trouiller S, Pereira B, Mrozek N, et al. Outcome of totally implantable venous-access port-related infections. Médecine et Maladies Infectieuses. 2016;46(1):32-38. doi:10.1016/j.medmal.2015.12.006
BibTeX
@article{Vidal2016,
author = {Vidal, M and Genillon, J P and Forestier, E and Trouiller, S and Pereira, B and Mrozek, N and Aumeran, C and Lesens, O},
title = {Outcome of totally implantable venous-access port-related infections},
journal = {Médecine et Maladies Infectieuses},
year = {2016},
volume = {46},
number = {1},
pages = {32--38},
doi = {10.1016/j.medmal.2015.12.006}
}
EUVIMED